Please go ahead.Īndrew Benson: Thank you. I would now like to turn the conference over to Andrew Benson, Head of Investor Relations. Please note that this event is being recorded. After today's presentation, there will be an opportunity to ask questions. All participants will be in listen-only mode. Operator: Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. Reported EPS is $-0.31 EPS, expectations were $0.24. (NASDAQ: CODX) Q2 2023 Earnings Call Transcript August 10, 2023Ĭo-Diagnostics, Inc. This allows the company to play its part in creating COVID-safe schools, COVID-safe businesses, and COVID-safe communities, said Co-Diagnostics.Co-Diagnostics, Inc. The company added that Logix Smart COVID-19 tests now also work with self-administered, saliva-based collection kits that can be processed via high throughput protocols to return results without sacrificing accuracy. RT-PCR also provides higher fast data throughput and sensitivity than antigen tests. “RT-PCR tests are recognized for their important role in detection of the SARS-CoV-2 virus, and the global demand for PCR-based diagnostics like our Logix Smart COVID-19 test kit continues,” noted the company.Īccording the Centers for Disease Control and Prevention, RT-PCR remains the 'gold standard' for clinical diagnostic detection of SARS-CoV-2. “The reach of the company's coronavirus test has also expanded to high-throughput laboratories which serve a nationwide customer base,” said the company.Ĭo-Diagnostics said the sales generated by the collaborations and “important lab relationships” continue, and the need for “high quality, high volume” RT-PCR (or reverse-transcriptase polymerase chain reaction) tests like its Logix Smart COVID-19 test remains in “significant demand.” ![]() READ: Co-Diagnostics wins increased US patent protection for its CoPrimer technology used in its coronavirus test kitĬo-Diagnostics also told shareholders that it continued to participate in successful joint government and private collaborations in several states. "In light of the upcoming flu season and the ongoing coronavirus pandemic, the company is augmenting our COVID-19 testing with our forthcoming respiratory virus panel, which will test for and differentiate between influenza A, influenza B and COVID-19, and will be introduced to our expanded customer base in the United States and across the world,” said the company. In an update on Tuesday, the Salt Lake City, Utah-based company said that it was “augmenting” its COVID-19 test kit with a respiratory virus panel to prepare for the flu season. DisclaimerĬo-Diagnostics Inc ( NASDAQ:CODX), a molecular diagnostics company, provided shareholders with an operational update on its CoPrimer technology-based Logix Smart COVID-19 test kit. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation. Proactive will on occasion use automation and software tools, including generative AI. The team also has access to and use technologies to assist and enhance workflows. Our human content creators are equipped with many decades of valuable expertise and experience. ![]() Proactive has always been a forward looking and enthusiastic technology adopter. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. This is content that excites and engages motivated private investors. We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. ![]() Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. All our content is produced independently by our experienced and qualified teams of news journalists. Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. She has also worked for Agency France Presse, Business Standard, and the Financial Times in London. Previously, as a senior writer for Forbes India based in New York she has interviewed Fortune 500 CEOs and reported on state visits to Washington from the White House. ![]() She has reported on markets, foreign policy, and business from North America, Asia, and Europe. Uttara is the Business News Editor at Proactive and oversees the creation of feature articles and marquee CEO interviews.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |